TAM
LTRN icon

Tocqueville Asset Management’s Lantern Pharma LTRN Stock Holding History

Tocqueville Asset Management’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17,000
Closed -$62.4K – 552
2024
Q3 		$62.4K Hold
17,000
– – ﹤0.01% 522
2024
Q2 		$79.4K Sell
17,000
-2,000
-11% -$12K ﹤0.01% 517
2024
Q1 		$167K Buy
+19,000
New +$102K ﹤0.01% 517

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return

Tocqueville Asset Management's LTRN Position: Q4 2024 in Review

Tocqueville Asset Management sold out of Lantern Pharma (LTRN) in Q4 2024, closing a stake of 17,000 shares — an estimated $62.4K sold.

Tocqueville Asset Management first reported a position in LTRN in Q1 2024 and held it in 3 quarters. The position peaked at $167K in Q1 2024. 32 funds tracked by Wall St. Rank hold LTRN as of Q4 2024.

  • Tocqueville Asset Management reported no remaining Lantern Pharma position as of Q4 2024 after selling out during the quarter.
  • Tocqueville Asset Management sold 17,000 Lantern Pharma shares in Q4 2024, an estimated $62.4K.
  • Tocqueville Asset Management first reported a position in Lantern Pharma in Q1 2024 and held it in 3 quarters.
  • Tocqueville Asset Management's Lantern Pharma position peaked at $167K in Q1 2024.
  • 32 funds tracked by Wall St. Rank held Lantern Pharma as of Q4 2024.

Based on Tocqueville Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.